Katia Bruxvoort, PhD, MPH
Division of Epidemiologic Research
Dr. Katia Bruxvoort is an infectious disease epidemiologist. She is a co-investigator on several post-licensure vaccine safety and effectiveness studies (hepatitis B vaccine, shingles vaccine, influenza vaccines). Other current research includes understanding patterns of antimicrobial use and resistance in urinary tract infections and improving uptake and adherence to pre-exposure prophylaxis (PrEP) for HIV. She has broad interests in infectious disease prevention, targeted treatment, and the intersection of social needs and health.
She was a post-doctoral research fellow for the Department of Research & Evaluation from 2017 to 2021. Before joining Kaiser Permanente, Dr. Bruxvoort worked in Tanzania as an epidemiologist with the London School of Hygiene and Tropical Medicine. She led large-scale studies to evaluate the national rollout of malaria rapid diagnostic tests and tested novel interventions to improve adherence to antimalarial treatment.
Areas of Focus
- Infectious diseases
- Vaccine safety and effectiveness
- Antimicrobial resistance
- Medication adherence
London School of Hygiene and Tropical Medicine
Honors and Awards
- Young Investigator Honorable Mention, American Society of Tropical Medicine and Hygiene